Thanks Tamborinewell there you goif they wanted to, they could charge $10 A YEAR subscription and reach their $100 million ARR target.Theyre obviously confident of reaching it without heading down that path in the near future
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025